G8 Education enters trading halt: Here's what you need to know

G8 Education Ltd (ASX:GEM) looks set to continue delivering market-smashing performance.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of childcare centre operator G8 Education Ltd (ASX: GEM) have entered into a trading halt today after the company announced that it had contracts in place to acquire 20 childcare and education centres for a total of $36.7 million.

The company will issue approximately 20.4 million shares at an issue price of $4.91 per share – a 4.5% discount compared to their most recent closing price of $5.14 – to raise a total of $100 million to fund the acquisitions.

The company said that 17 of the 20 centres were being purchased for $24.35 million while a further $1.3 million payment was conditional on an earnings before interest and tax (EBIT) target being achieved in the 12 months post settlement. The purchase price represents 3.98x anticipated EBIT for the 12 months post settlement which is in line with the company's stated acquisition plan.

The other three centres are considered to be premium centres. G8 Education gained options to purchase these centres after it acquired 91 centres back in March this year. These three centres will cost G8 Education $12.35 million which represents 6.19x anticipated EBIT. When combined, the 20 centres will increase the total number of places in G8 Education's Australian portfolio by 1,343 per day, and will be earnings per share accretive from settlement date.

The remainder of the $100 million raised by the company will be used to strengthen the company's balance sheet to allow it to continue acquiring businesses around the country to strengthen its market position. Indeed, this strategy has allowed the company to deliver enormous returns to shareholders in recent years and with plenty of room left to expand, I expect it will continue to do so in the future.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »